Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis

<div>Allopurinol altered markers of cell replication in PSE cells after 2 days of treatment. Data is expressed relative to the control treated cells (<span class="inline" id="M93"></span>, <span class="inline" id="M94"></span>). Bars with asterisks are significantly different than the control-treated cells (<span class="inline" id="M95"></span>, Dunnett’s multicomparison test).</div>

BioMed Research International

fig3

Figure 3

Figure 3: Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis 

Figure 3 | Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis 